Encapsulate is developing an automated tumor-on-a-chip system that can grow patients cancer cells outside the body, and test the efficacy of chemotherapeutic drugs against them to advocate for the best course of treatment. This can help the oncologists in deciding the first-line of treatment for patients prior to starting treatment. Using this platform and choosing the most efficient cancer drug from the beginning will I) reduce the number of chemotherapy cycles a patient undergoes, II) lower the costs and duration of treatment, III) increase the success rates of treatment, and IV) improve the patient’s overall quality of life. Our mission is to offer personalized cancer therapy screening in the most accurate, expedited, and cost-effective manner.
Armin Tahmasbi Rad - Co-Founder and CEO